8-K: Intelligent Bio Solutions Inc. Announces 118% Growth in Customer Employee Base

Intelligent Bio Solutions Inc. reports a significant 118% year-over-year increase in its customer employee base, reaching an estimated total of 1.4 million employees.

Summary

• Intelligent Bio Solutions Inc. (INBS) has announced a 118% year-over-year increase in the estimated total number of employees across its customer base.
• The estimated customer employee base has grown to 1.4 million as of June 30, 2024, an increase of 720,000 employees compared to the previous year's increase of 329,000.
• The average number of global employees per new customer in the 2024 fiscal year was 6,500, more than double the 3,000 employees per new customer in the prior fiscal year.
• The company's Intelligent Fingerprinting Drug Screening System is gaining traction, particularly in industries with high occupational health and safety risks.
• The system is designed to detect the use of certain illicit drugs within the prior 16-24 hour period.
• The customer employee base estimate of 1.4 million employees was derived by aggregating publicly available data on the total number of employees for each INBS customer.

Sentiment

Score: 8

Explanation: The document conveys a very positive sentiment due to the significant growth in the customer base and the increased adoption of the company's technology. The company is clearly gaining traction in its target market.

Positives

• The company's customer employee base has grown significantly, indicating increased adoption of their drug screening system.
• The average number of employees per new customer has more than doubled, suggesting larger clients are being acquired.
• The company's technology is being recognized for its role in safeguarding workplace safety in high-risk industries.

Negatives

• The 1.4 million employee figure is an estimate based on publicly available data and may not reflect the exact number of employees using the INBS system.
• The company does not have data on the percentage of employees tested using their system at each customer.

Risks

• The company's future success depends on its ability to continue developing and commercializing its drug and diagnostic tests.
• The company's ability to realize commercial benefits from partnerships and collaborations is not guaranteed.
• Securing regulatory approvals for their products is subject to uncertainty.

Future Outlook

The company aims to continue expanding its reach and providing innovative drug screening solutions for industries where safety is paramount. They also acknowledge that forward-looking statements are subject to risks and uncertainties.

Management Comments

• Harry Simeonidis, President and CEO, stated that the growth highlights the drug screening technology's critical role in safeguarding workplace safety.
• The company's mission is to work closely with customers to identify areas where the risk of impairment from illicit drug use is most concerning.

Industry Context

This announcement reflects a growing trend in industries with high safety risks to adopt advanced drug screening technologies to ensure employee fitness for work. The company is positioning itself as a leader in this space.

Comparison to Industry Standards

• The 118% growth in customer employee base is a strong indicator of market acceptance, but specific comparisons to competitors are not provided in the document.
• The average of 6,500 employees per new customer is a positive metric, suggesting the company is attracting larger clients than in the previous year.
• Without specific competitor data, it's difficult to benchmark the growth against industry standards, but the company's focus on high-risk industries is a strategic move.

Stakeholder Impact

• Shareholders will likely view the significant growth in the customer base positively.
• Employees may benefit from the company's growth and success.
• Customers in high-risk industries will benefit from the company's drug screening solutions.
• Suppliers may see increased demand for their products and services.

Next Steps

• The company will continue to expand its reach and provide innovative drug screening solutions.
• The company will work closely with customers to identify areas where the risk of impairment from illicit drug use is most concerning.

Key Dates

Keywords

drug testing, fingerprinting, workplace safety, employee screening, non-invasive technology, occupational health, drug screening system, Intelligent Bio Solutions